Skip directly to content

Pfizer update on the Competition Appeal Tribunal



We are pleased that the Competition Appeal Tribunal has overturned the Competition and Markets Authority's finding that Pfizer abused its dominant position – along with the associated fine. Our priority has always been to ensure a sustainable supply of our medicines to UK patients and this was at the heart of our decision to divest this medicine.